comparemela.com

Latest Breaking News On - Roel schaapveld - Page 1 : comparemela.com

InteRNA Technologies Announces U S FDA Clearance of IND Application for Phase I Clinical Trial with Lead microRNA Candidate INT-1B3 in Patients with Advanced Solid Tumors

IND approval enables clinical trial advancement and enrollment of dose expansion cohorts in the US InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based

InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board

Adding deep preclinical and clinical immuno-oncology expertise to expand InteRNA's preclinical pipeline and accelerate clinical-stage lead candidate INT-1B3 InteRNA Technologies, a clinical-stage

InteRNA Technologies: InteRNA Appoints Established Oncology Innovator Andrea van Elsas, PhD, to its Supervisory Board

InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment of Andrea van Elsas, PhD, as a new member

InteRNA Technologies Awarded € 2 7M Clinical Innovation Credit from Dutch Government

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.